Gracell Biotechnologies Inc. Sponsored ADR Debt to Equity Ratio 2022-2023 | GRCL

Current and historical debt to equity ratio values for Gracell Biotechnologies Inc. Sponsored ADR (GRCL) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Gracell Biotechnologies Inc. Sponsored ADR debt/equity for the three months ending September 30, 2023 was .
Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2023-09-30 $0.04B $0.22B 0.17
2023-06-30 $0.03B $0.16B 0.21
2023-03-31 $0.04B $0.18B 0.22
2022-12-31 $0.04B $0.20B 0.20
2022-09-30 $0.04B $0.22B 0.20
2022-06-30 $0.04B $0.24B 0.18
2022-03-31 $0.04B $0.26B 0.16
2021-12-31 $0.04B $0.29B 0.13
2021-09-30 $0.03B $0.31B 0.11
2021-06-30 $0.03B $0.32B 0.11
2021-03-31 $0.03B $0.34B 0.09